Videos | Stents Bioresorbable
Juan Granada, M.D., executive director and chief scientific officer of the Cardiovascular Research Foundation's Skirball ...
November 09, 2016
Videos | Structural Heart
Brijeshwar Maini, M.D., and Brian Bethea, M.D., from Tenet Florida’s structural heart program, explain the importance of ...
November 09, 2016
News | Stents
November 9, 2016 – Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin ...
November 09, 2016Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Videos | Hypertension
Krishna Rocha-Singh, M.D., Prairie Vascular Institute, Springfield, Ill., explains advancements in device therapy for ...
November 08, 2016
Videos | Cath Lab
David Kandzari, M.D., director of interventional cardiology and chief scientific officer, Piedmont Heart Institute ...
November 08, 2016
Videos | Heart Valve Technology
Studies have shown transcatheter aortic valve replacement (TAVR) has an increased risk of stroke and cerebral damage due ...
November 08, 2016Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | Heart Valve Technology
Edwards Lifesciences Corp. recently announced new data demonstrating dramatic and sustained improvements in quality of life for severe aortic stenosis (AS) patients at intermediate surgical risk treated with Edwards transcatheter heart valves. Study results were presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Washington, D.C.
November 07, 2016
Feature | Left Atrial Appendage (LAA) Occluders
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
November 07, 2016
News | Heart Valve Technology
Keystone Heart Ltd. announced that data presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2016 scientific symposium demonstrate an increase in brain lesions for patients following transcatheter aortic valve replacement (TAVR) procedures, which were significantly associated with delirium.
November 07, 2016Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Stents
November 7, 2016 – Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (OCT) ...
November 07, 2016
News | Heart Valve Technology
November 7, 2016 – A multicenter randomized trial evaluating the role of embolic protection using the Sentinel device ...
November 07, 2016
News | Stents
Polymer-Free Drug-Coated Stents More Effective Than Bare-metal Stents in High Bleeding Risk Patients
November 7, 2016 – The two-year results from LEADERS FREE, the first randomized clinical trial dedicated to high ...
November 07, 2016Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Stents Bioresorbable
The 28th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Oct. 29-Nov. 3 in Washington, D.C., featured a number of first report investigations on novel stents that could become the next generation of bioresorbable stents in patients.
November 07, 2016
News | Stents
November 7, 2016 – The large multinational randomized BIONICS study found that a novel elastic polymer coated ...
November 07, 2016
News | Cath Lab
November 7, 2016 – Two-year results from the COLOR Trial, the first large-scale multicenter prospective study of its ...
November 07, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now